Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis

被引:369
作者
Tobin, RW
Pope, CE
Pellegrini, CA
Emond, MJ
Sillery, J
Raghu, G
机构
[1] Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Div Gastroenterol, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Surg, Seattle, WA 98195 USA
[4] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
关键词
D O I
10.1164/ajrccm.158.6.9804105
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal interstitial lung disease (ILD) of unknown etiology. introduction of acid into the respiratory tree can produce pulmonary fibrosis. Gastroesophageal reflux (GER) has previously been associated with several other respiratory conditions, including pneumonia, bronchitis, and asthma. To investigate prospectively the possible association of CER and IPF, 17 consecutive patients with biopsy-proven IPF and eight control patients with ILD other than IPF underwent dual-channel, ambulatory esophageal pH monitoring. Sixteen of 17 patients with IPF had abnormal distal and/or proximal esophageal acid exposure compared with four of eight control patients (p = 0.02). In the patients with IPF, mean percent distal total (13.6 versus 3.34, p = 0.006), distal upright (12.4 versus 5.1, p = 0.04), distal supine (14.7 versus 0.88, p = 0.02), and proximal supine (7.48 versus 0.24, p = 0.04) esophageal acid exposure times were significantly greater than those in control patients. Only four patients with IPF (25%) with increased acid exposure had typical reflux symptoms such as heartburn or regurgitation. Patients with IPF have a high prevalence of increased esophageal acid exposure, usually without typical GER symptoms, GER in these patients fends to occur at: night and extend into the proximal esophagus. Acid reflux may be a contributing factor in the pathogenesis of IPF.
引用
收藏
页码:1804 / 1808
页数:5
相关论文
共 32 条
[1]   RESPIRATORY COMPLICATIONS OF GASTROESOPHAGEAL REFLUX [J].
BARISH, CF ;
WU, WC ;
CASTELL, DO .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (10) :1882-1888
[2]  
DOBHAN R, 1993, AM J GASTROENTEROL, V88, P25
[3]   SIMULTANEOUS TRACHEAL AND ESOPHAGEAL PH MONITORING - INVESTIGATING REFLUX-ASSOCIATED ASTHMA [J].
DONNELLY, RJ ;
BERRISFORD, RG ;
JACK, CIA ;
TRAN, JA ;
EVANS, CC .
ANNALS OF THORACIC SURGERY, 1993, 56 (05) :1029-1034
[4]   EVALUATION OF STEROID-THERAPY IN ASPIRATION PNEUMONITIS [J].
DOWNS, JB ;
CHAPMAN, RL ;
MODELL, JH ;
HOOD, CI .
ANESTHESIOLOGY, 1974, 40 (02) :129-135
[5]  
DUCOLONE A, 1987, AM REV RESPIR DIS, V135, P327
[6]   FREQUENCY AND SITE OF GASTROESOPHAGEAL REFLUX IN PATIENTS WITH CHEST SYMPTOMS - STUDIES USING PROXIMAL AND DISTAL PH MONITORING [J].
GASTAL, OL ;
CASTELL, JA ;
CASTELL, DO .
CHEST, 1994, 106 (06) :1793-1796
[7]   Quantitative aspiration during sleep in normal subjects [J].
Gleeson, K ;
Eggli, DF ;
Maxwell, SL .
CHEST, 1997, 111 (05) :1266-1272
[8]  
Hamman L, 1944, B JOHNS HOPKINS HOSP, V74, P177
[9]   Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome [J].
Harding, SM ;
Richter, JE ;
Guzzo, MR ;
Schan, CA ;
Alexander, RW ;
Bradley, LA .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (04) :395-405
[10]   PROXIMAL ESOPHAGEAL PH-METRY IN PATIENTS WITH REFLUX LARYNGITIS [J].
JACOB, P ;
KAHRILAS, PJ ;
HERZON, G .
GASTROENTEROLOGY, 1991, 100 (02) :305-310